|
Tofacitinib in Juvenile Idiopathic Arthritis
RECRUITINGSponsored by Consorci Sanitari de l'Alt Penedès i Garraf
Actively Recruiting
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
Started2026-02-02
Est. completion2027-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07211932
Summary
This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.
Eligibility
Healthy volunteers accepted
Inclusion criteria: Diagnosis of juvenile idiopathic arthritis (JIA) documented in the medical record by the treating rheumatologist. Documentation in the medical record of the medical indication for tofacitinib treatment, with a diagnostic justification related to JIA. Age under 18 years at the time of the treatment indication with tofacitinib. Exclusion criteria: Participants diagnosed with any of the following conditions: Reactive arthritis Arthritis associated with inflammatory bowel disease Arthritis associated with another autoimmune disease
Conditions2
ArthritisJuvenile Idiopathic Arthritis (JIA)
Interventions1
Related trials
- Advanced Therapeutics in Rheumatoid Arthritis (RA) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis — Duke University
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease — National Institute of Dental and Craniofacial Research (NIDCR)
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response — University of Nebraska
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty — NYU Langone Health
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorConsorci Sanitari de l'Alt Penedès i Garraf
Started2026-02-02
Est. completion2027-12
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07211932